X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BFRI

Closed

Biofrontera Inc

0.688
-0.024 (-3.37%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.7115
Day's Range: 0.640101 - 0.7
Send
When Written:
 
0.61
Biofrontera Inc. is a biopharmaceutical company that focuses on the development and commercialization of dermatological drugs and medical devices for the treatment of skin diseases and conditions. The company's flagship product is Ameluz, a prescription drug used in the treatment of actinic keratosis, a type of skin cancer. Biofrontera also produces the BF-RhodoLED, a medical device used in photodynamic therapy. The company was founded in 1997 and is headquartered in Leverkusen, Germany, with a subsidiary in Woburn, Massachusetts. It is listed on the NASDAQ stock exchange under the ticker symbol BFRA.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X